Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Ringshausen, Felix C ^a,b   Nienhaus, Albert ^c   Schablon, Anja ^c   Schlösser, Stephan ^a   Schultze Werninghaus, Gerhard ^a   Rohde, Gernot ^a,d  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Spital Bülach ^*  (Switzerland)

^c Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services   (Germany)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; OBSERVATIONAL STUDY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PATIENT SAFETY; PROSPECTIVE STUDY; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS; ADOLESCENT; COMPARATIVE STUDY; EVALUATION; GERMANY; IMMUNOLOGY; MASS SCREENING; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; SECRETION; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; BACTERIOLOGICAL TECHNIQUES; COHORT STUDIES; FEMALE; GERMANY; HEALTH PERSONNEL; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 77955475492     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-220     Document Type: Article

References (48)

1. American Thoracic Society Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000, 49:1-51. American Thoracic Society.
2. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Holscher C, Kampmann B, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009, 33:956-973. 10.1183/09031936.00120908, 19407047.
3. Diel R, Seidler A, Nienhaus A, Rusch-Gerdes S, Niemann S. Occupational risk of tuberculosis transmission in a low incidence area. Respir Res 2005, 6:35. 10.1186/1465-9921-6-35, 1087884, 15831092.
4. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007, 11:593-605.
5. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999, 159:15-21.
6. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007, 146:340-354.
7. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, Reingold AL, Colford JM, Riley LW, Menzies D. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006, 174:349-355. 10.1164/rccm.200604-472OC, 2648116, 16690977.
8. Diel R, Forssbohm M, Loytved G, Haas W, Hauer B, Maffei D, Magdorf K, Nienhaus A, Rieder HL, Schaberg T, et al. [Recommendations for environmental contact tracing in tuberculosis. German Central Committee against Tuberculosis]. Gesundheitswesen 2007, 69:488-503. 10.1055/s-2007-980089, 17926267.
9. Centers for Disease Control and Prevention Guidelines for the investigation of contacts of persons with infectious tuberculosis; recommendations from the National Tuberculosis Controllers Association and CDC, and Guidelines for using the QuantiFERON®-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005, 54(RR-15):1-55. Centers for Disease Control and Prevention.
10. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, Lugos MD, Donkor SA, Adetifa IM, de Jong BC, Aiken AM, et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 2007, 4:e192. 10.1371/journal.pmed.0040192, 1891317, 17564487.
11. Hill PC, Jeffries DJ, Brookes RH, Fox A, Jackson-Sillah D, Lugos MD, Donkor SA, de Jong BC, Corrah T, Adegbola RA, McAdam KP. Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. PLoS ONE 2007, 2:e183. 10.1371/journal.pone.0000183, 1779806, 17264885.
12. Pai M, Joshi R, Dogra S, Zwerling AA, Gajalakshmi D, Goswami K, Reddy MV, Kalantri A, Hill PC, Menzies D, Hopewell PC. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 2009, 13:84-92.
13. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006, 174:831-839. 10.1164/rccm.200511-1783OC, 16799072.
14. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Dheda K, Kalantri S. Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol 2006, 1:7. 10.1186/1745-6673-1-7, 1481589, 16722616.
15. Katiyar SK, Sampath A, Bihari S, Mamtani M, Kulkarni H. Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2008, 12:1146-1152.
16. Pollock NR, Kashino SS, Napolitano DR, Sloutsky A, Joshi S, Guillet J, Wong M, Nardell E, Campos-Neto A. Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay results. Infect Control Hosp Epidemiol 2009, 30:392-395. 10.1086/596606, 19236281.
17. Ribeiro S, Dooley K, Hackman J, Loredo C, Efron A, Chaisson RE, Conde MB, Boechat N, Dorman SE. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis 2009, 9:23. 10.1186/1471-2334-9-23, 2651889, 19250549.
18. Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EE, Reddy MV, Kalantri S, Schwartzman K, Behr MA, Menzies D, Pai M. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS ONE 2008, 3:e1850. 10.1371/journal.pone.0001850, 2266993, 18365006.
19. Detjen AK, Loebenberg L, Grewal HM, Stanley K, Gutschmidt A, Kruger C, Du Plessis N, Kidd M, Beyers N, Walzl G, Hesseling AC. Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol 2009, 16:1170-1175. 10.1128/CVI.00168-09, 2725540, 19535542.
20. van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, Badri M, Zumla A, Sechi LA, Bateman ED, Dheda K. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med 2009, 180:49-58. 10.1164/rccm.200811-1704OC, 19342414.
21. Chee CB, Lim LK, Barkham TM, Koh DR, Lam SO, Shen L, Wang YT. Use of a T cell interferon-gamma release assay to evaluate tuberculosis risk in newly qualified physicians in Singapore healthcare institutions. Infect Control Hosp Epidemiol 2009, 30:870-875. 10.1086/599284, 19637958.
22. Yoshiyama T, Harada N, Higuchi K, Nakajima Y, Ogata H. Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-gamma assays. Epidemiol Infect 2009, 1-8.
23. Franken WP, Koster BF, Bossink AW, Thijsen SF, Bouwman JJ, van Dissel JT, Arend SM. Follow-up study of tuberculosis-exposed supermarket customers with negative tuberculin skin test results in association with positive gamma interferon release assay results. Clin Vaccine Immunol 2007, 14:1239-1241. 10.1128/CVI.00185-07, 2043314, 17626157.
24. Franken WP, Arend SM, Thijsen SF, Bouwman JJ, Koster BF, van Dissel JT, Bossink AW. Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts. Int J Tuberc Lung Dis 2008, 12:1286-1294.
25. Perry S, Sanchez L, Yang S, Agarwal Z, Hurst P, Parsonnet J. Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol 2008, 15:425-432. 10.1128/CVI.00398-07, 2268272, 18199741.
26. Brodhun B, Altmann D, Haas W. [Report on the epidemiology of tuberculosis in Germany 2007] 2009, Berlin: Robert Koch-Institut (RKI).
27. Centers for Disease Control and Prevention Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005, 54(RR-17):1-141. Centers for Disease Control and Prevention.
28. Ringshausen FC, Schlosser S, Nienhaus A, Schablon A, Schultze-Werninghaus G, Rohde G. In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis. J Occup Med Toxicol 2009, 4:11. 10.1186/1745-6673-4-11, 2698921, 19505310.
29. Cellestis: QuantiFERON®-TB Gold In-Tube package insert. , http://www.cellestis.com/IRM/Company/ShowPage.aspx?CPID=1255
30. Hosmer D, Lemeshow S. Applied logistic regression 2000, New York, NY: John Wiley & Sons, 2.
31. Nienhaus A, Schablon A, Bacle CL, Siano B, Diel R. Evaluation of the interferon-gamma release assay in healthcare workers. Int Arch Occup Environ Health 2008, 81:295-300. 10.1007/s00420-007-0212-1, 17605033.
32. Nienhaus A, Schablon A, Diel R. Interferon-gamma release assay for the diagnosis of latent TB infection--analysis of discordant results, when compared to the tuberculin skin test. PLoS ONE 2008, 3:e2665. 10.1371/journal.pone.0002665, 2441828, 18628829.
33. Vinton P, Mihrshahi S, Johnson P, Jenkin GA, Jolley D, Biggs BA. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol 2009, 30:215-221. 10.1086/595695, 19191484.
34. Richeldi L, Ewer K, Losi M, Roversi P, Fabbri LM, Lalvani A. Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax 2006, 61:180. 10.1136/thx.2005.049759, 2104569, 16443712.
35. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 2009, 4:e8517. 10.1371/journal.pone.0008517, 2795193, 20041113.
36. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006, 27:442-448. 10.1086/504358, 16671023.
37. Bakir M, Millington KA, Soysal A, Deeks JJ, Efee S, Aslan Y, Dosanjh DP, Lalvani A. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 2008, 149:777-787. 2730556, 18936496.
38. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008, 177:1164-1170. 10.1164/rccm.200711-1613OC, 18276940.
39. Hill PC, Jackson-Sillah DJ, Fox A, Brookes RH, de Jong BC, Lugos MD, Adetifa IM, Donkor SA, Aiken AM, Howie SR, et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS ONE 2008, 3:e1379. 10.1371/journal.pone.0001379, 2147055, 18167540.
40. Haldar P, Thuraisingham H, Hoskyns W, Woltmann G. Contact screening with single-step TIGRA testing and risk of active TB infection: the Leicester cohort analysis [abstract]. Thorax 2009, 64(Suppl IV):A10.
41. Kik SV, Franken WP, Mensen M, Cobelens FG, Kamphorst M, Arend SM, Erkens C, Gebhard A, Borgdorff MW, Verver S. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010, 35:1346-53. 10.1183/09031936.00098509, 19840963.
42. Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted?. Trends Mol Med 2007, 13:175-182. 10.1016/j.molmed.2007.03.004, 17418641.
43. Pai M. Spectrum of latent tuberculosis - existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol 2010, 8:242. 10.1038/nrmicro2236-c1, 20084059.
44. Pai M, O'Brien R. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?. PLoS Med 2007, 4:e208. 10.1371/journal.pmed.0040208, 1891321, 17564491.
45. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149:177-184.
46. Ringshausen FC, Tannapfel A, Nicolas V, Weber A, Duchna HW, Schultze-Werninghaus G, Rohde G. A fatal case of spinal tuberculosis mistaken for metastatic lung cancer: recalling ancient Pott's disease. Ann Clin Microbiol Antimicrob 2009, 8:32. 10.1186/1476-0711-8-32, 2784744, 19930560.
47. Ringshausen FC, Schlösser S, Schablon A, Nienhaus A, Schultze-Werninghaus G, Rohde G. Frequency of discordant results in interferon-gamma release assay serial testing for latent tuberculosis infection in health care workers [abstract]. Eur Respir J 2008, 32(Suppl 52):447s.
48. Ringshausen FC, Nienhaus A, Schablon A, Schlösser S, Schultze-Werninghaus G, Rohde G. Predictors of consistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers [abstract]. Swiss Medical Forum 2010, 10(Suppl 50):9s.